Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP584299.RAzECbVWJEPtW_IlVaN1VazmWE1sYb3CcuayLokHpqeXU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP584299.RAzECbVWJEPtW_IlVaN1VazmWE1sYb3CcuayLokHpqeXU130_assertion type Assertion NP584299.RAzECbVWJEPtW_IlVaN1VazmWE1sYb3CcuayLokHpqeXU130_head.
- NP584299.RAzECbVWJEPtW_IlVaN1VazmWE1sYb3CcuayLokHpqeXU130_assertion description "[Due to the functions of PGRN in neuronal survival and the clinicopathological overlaps between FTD and other dementias it is likely that reduced PGRN expression is associated with the progression of other neurodegenerative brain diseases including Alzheimer's disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP584299.RAzECbVWJEPtW_IlVaN1VazmWE1sYb3CcuayLokHpqeXU130_provenance.
- NP584299.RAzECbVWJEPtW_IlVaN1VazmWE1sYb3CcuayLokHpqeXU130_assertion evidence source_evidence_literature NP584299.RAzECbVWJEPtW_IlVaN1VazmWE1sYb3CcuayLokHpqeXU130_provenance.
- NP584299.RAzECbVWJEPtW_IlVaN1VazmWE1sYb3CcuayLokHpqeXU130_assertion SIO_000772 17168647 NP584299.RAzECbVWJEPtW_IlVaN1VazmWE1sYb3CcuayLokHpqeXU130_provenance.
- NP584299.RAzECbVWJEPtW_IlVaN1VazmWE1sYb3CcuayLokHpqeXU130_assertion wasDerivedFrom befree-2016 NP584299.RAzECbVWJEPtW_IlVaN1VazmWE1sYb3CcuayLokHpqeXU130_provenance.
- NP584299.RAzECbVWJEPtW_IlVaN1VazmWE1sYb3CcuayLokHpqeXU130_assertion wasGeneratedBy ECO_0000203 NP584299.RAzECbVWJEPtW_IlVaN1VazmWE1sYb3CcuayLokHpqeXU130_provenance.